1002-046 (Study 3) Phase 3 Efficacy Study – Safety & Tolerability

1002-046 (Study 3) Phase 3 Efficacy Study – Safety & Tolerability

Overview of Adverse Events

Format

PNG

Source

Esperion Therapeutics, Inc.

Downloads